Validation Study of the OHIO Chamber in Patients with Japanese Cedar Pollinosis

被引:29
作者
Hashiguchi, Kazuhiro [1 ]
Tang, Huaipeng [2 ]
Fujita, Toshio [3 ]
Suematsu, Kiyochika [4 ]
Tsubaki, Shigekazu [5 ]
Nagakura, Hitoshi [6 ]
Kitajima, Sei [7 ]
Gotoh, Minoru [9 ]
Okubo, Kimihiro [8 ]
机构
[1] Kitasato Inst Hosp, Dept Otolaryngol, Minato Ku, Tokyo 1088642, Japan
[2] Shinryo Corp, Ctr Res & Dev, Tsukuba, Ibaraki, Japan
[3] Shinryo Corp, Engn & Construct Div 1, Tokyo, Japan
[4] Tokyo Res Ctr Clin Pharmacol Co Ltd, Chamber Business Dept, Tokyo, Japan
[5] Samoncho Clin, Tokyo, Japan
[6] Nagakura Allergy Clin, Tokyo, Japan
[7] Kitajima Otolaryngol Clin, Tokyo, Japan
[8] Nippon Med Sch, Dept Otolaryngol, Tokyo 113, Japan
[9] Hokusoh Hosp, Nippon Med Sch, Dept Otolaryngol, Chiba, Japan
关键词
Allergen exposure; Clinical trial; Japanese cedar pollen; Japanese patients; OHIO Chamber; Seasonal allergic rhinitis; Validation study; SEASONAL ALLERGIC RHINITIS; ENVIRONMENTAL EXPOSURE UNIT; GRASS-POLLEN; PLACEBO; CETIRIZINE; CHALLENGE; ONSET; HYDROCHLORIDE; INHALATION; SYMPTOMS;
D O I
10.1159/000189197
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: An artificial exposure chamber (OHIO Chamber), which allows dispersal of a fixed concentration of Japanese cedar (JC) pollen under stable conditions, was constructed. This study was conducted to identify the exposure conditions assuring validity of the clinical tests conducted using this chamber. Methods: Twenty-four adult patients with JC pollinosis were exposed to different concentrations of JC pollen: 0 (only during the summer period), 4,000, 8,000 and 12,000 grains/m(3), and the nasal and ocular symptoms were self-assessed during a 4-hour period of exposure. The amount of nasal discharge was measured and the sneezing frequency was recorded. This study was conducted twice during the summer and winter periods, i.e. non-pollen seasons. The reproducibility of the symptoms between the two seasons was assessed. Results: None of the subjects developed any symptom at the pollen concentration of 0 grains/m(3). No significant differences in the time to the onset of symptoms were found between the summer and winter study, regardless of the pollen concentration. There were no significant differences between the summer and winter study in the total symptom score and total nasal symptom score at any pollen concentration, suggesting the very favorable reproducibility of symptoms. Conclusions: Efficient and reproducible results are obtained in patients exposed to JC pollen in the OHIO Chamber. The results suggest the conditions of JC pollen exposure have scientific validity and the OHIO Chamber has the potential to contribute significantly to basic and clinical studies of JC pollinosis. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:141 / 149
页数:9
相关论文
共 19 条
[1]   Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit [J].
Berkowitz, RB ;
Woodworth, GG ;
Lutz, C ;
Weiler, K ;
Weiler, J ;
Moss, M ;
Meeves, S .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (01) :38-45
[2]   Allergic rhinitis and its impact on asthma [J].
Bousquet, J ;
van Cauwenberge, P ;
Khaltaev, N ;
Ait-Khaled, N ;
Annesi-Maesano, I ;
Bachert, C ;
Baena-Cagnani, C ;
Bateman, E ;
Bonini, S ;
Canonica, GW ;
Carlsen, KH ;
Demoly, P ;
Durham, SR ;
Enarson, D ;
Fokkens, WJ ;
van Wijk, RG ;
Howarth, P ;
Ivanova, NA ;
Kemp, JP ;
Klossek, JM ;
Lockey, RF ;
Lund, V ;
Mackay, I ;
Malling, HJ ;
Meltzer, EO ;
Mygind, N ;
Okunda, M ;
Pawankar, R ;
Price, D ;
Scadding, GK ;
Simons, FER ;
Szczeklik, A ;
Valovirta, E ;
Vignola, AM ;
Wang, DY ;
Warner, JO ;
Weiss, KB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (05) :S147-S334
[3]  
Day J. H., 2006, Clinical and Experimental Allergy Reviews, V6, P31, DOI 10.1111/j.1365-2222.2005.00099.x
[4]   Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system [J].
Day, JH ;
Briscoe, M ;
Rafeiro, E ;
Chapman, D ;
Kramer, B .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (06) :474-481
[5]  
Enomoto T, 2007, J INVEST ALLERG CLIN, V17, P173
[6]  
Hashiguchi Kazuhiro, 2007, Allergol Int, V56, P125, DOI 10.2332/allergolint.O-06-453
[7]   Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit [J].
Horak, F ;
Stübner, UP ;
Zieglmayer, R ;
Harris, AG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) :956-961
[8]   Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion [J].
Horak, F ;
Toth, J ;
Marks, B ;
Stubner, UP ;
Berger, UE ;
Jager, S ;
Burtin, B ;
Duby, C .
ALLERGY, 1998, 53 (09) :849-856
[9]  
IMANAKA M, 1998, JPN J RHINOL, V37, P316
[10]   Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit [J].
Krug, N ;
Hohlfeld, JM ;
Geldmacher, H ;
Larbig, M ;
Heermann, R ;
LaVallee, N ;
Nguyen, DT ;
Petzold, U ;
Hermann, R .
ALLERGY, 2005, 60 (03) :354-359